Top Stories
Proposal to set up ‘Abraham Accords’ FDA office moves ahead
June 18, 2023
The bipartisan bill amended a direct reference to Israel to “Abraham Accord region” amid ongoing vacillation by the Israeli Health Ministry regarding the initiative.
The U.S. House of Representatives has given initial approval to a proposal to establish a Food and Drug Administration office in the countries signatory to the historic Abraham Accords. The initiative is part of a watershed plan to further strengthen regional ties and reduce America’s dependence on Chinese pharmaceutical supplies.
The bipartisan bill, which has been on the drawing board over the last year, amended a direct reference to Israel and referred to a bureau in the “Abraham Accord region” amid ongoing vacillation by the Israeli Health Ministry regarding whether to sign on with the project.
The plan comes at a time of ever-improving relations between Israel and four Arab countries that made peace as part of the landmark 2020 Abraham Accords, as well as concomitant pharmaceutical shortages in the United States, which is heavily reliant on China for its healthcare needs.